XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock award plan - (Tables)
6 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2020

 

9,663,677

$

38.72

 

  

 

  

Granted

 

2,282,914

63.38

 

  

 

  

Exercised

 

(475,942)

27.66

 

  

 

  

Forfeited/Cancelled

 

(439,189)

53.85

 

  

 

  

Outstanding at June 30, 2021

 

11,031,460

$

43.70

 

7.34

years

$

64,268

Vested or Expected to vest at June 30, 2021

 

5,192,055

$

49.23

 

8.62

years

$

16,236

Exercisable at June 30, 2021

 

5,255,302

$

37.17

 

5.89

years

$

47,129

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Six months ended

    

June 30, 2021

Risk-free interest rate

 

0.51% - 0.96%

Expected volatility

 

85.94% - 88.61%

Expected term

 

5.5 years

Summary of information on the Company's restricted stock

Restricted Stock Awards and Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2020

982,058

$

41.78

Granted

 

951,558

64.21

Vested

 

(319,127)

35.21

Forfeited

 

(82,059)

57.75

Unvested at June 30, 2021

 

1,532,430

$

56.23

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2021

    

2020

    

2021

    

2020

Research and development

$

13,443

$

8,562

$

27,168

$

16,741

Selling, general and administrative

 

12,256

 

8,348

 

24,238

 

15,389

Total

$

25,699

$

16,910

$

51,406

$

32,130